Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from BONESUPPORT HOLDING ...
Results from a new study, presented at the 33rd Annual Meeting of The European Bone & Joint Infection Society, showed complete wound healing in patients with chronic osteomyelitis treated with ...
Earnings call BONESUPPORT reported Q3 2025 net sales of SEK 294 million, up 24% YoY (34% in constant currency), with 59% constant currency growth in antibiotic-eluting CERAMENT products. U.S. CERAMENT ...
BONESUPPORT Holding AB delivered impressive results in its Q2 2025 earnings call, showcasing significant growth in net sales and strategic expansions in the orthobiologic market. According to ...
Credit: Shutterstock. Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler. The Food and Drug Administration (FDA) has cleared Cerament G for use as a bone void filler in skeletally ...
LONDON – Bonesupport AB has raised $37 million in private equity and debt to develop a pipeline of products that use its injectable biomimetic scaffold Cerament to deliver drugs to the bone and to ...
Bonesupport Holding AB (BONEX) presented its second quarter 2025 results on July 15, showcasing strong growth and record profitability as the company continues to expand its footprint in the ...
Welcome, everyone, to BONESUPPORT's Q3 2025 Results Call. My name is Torbjorn Skold, and since September 1, I'm the CEO of BONESUPPORT. With me here today is our CFO, Hakan Johansson. And together, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results